HLA-A, -B, -C, -DR, and -DQ Matching in Pancreas Transplantation: Effect on Graft Rejection and Survival

Area of Science:

• Immunogenetics
• Transplantation immunology
• Clinical outcomes research

Background:

• Optimizing donor selection is crucial for successful pancreas transplantation.
• Human Leukocyte Antigen (HLA) compatibility is a key factor in transplant success.
• The impact of specific HLA loci matching on pancreas transplant outcomes requires further clarification.

Purpose of the Study:

• To investigate the association between HLA matching and post-transplantation outcomes in pancreas recipients.
• To determine if HLA-A, -B, -C, -DR, and -DQ matching influences acute rejection, graft survival, and patient survival.
• To evaluate the cost-effectiveness of HLA matching in pancreas transplantation.

Main Methods:

• Single-center study analyzing 1219 pancreas transplants.
• Correlation analysis of post-transplantation outcomes with HLA-A, -B, -C, -DR, and -DQ matches and mismatches.
• Assessment of rejection rates, graft and patient survival, opportunistic infections, and associated hospital costs.

Main Results:

• Acute rejection risk increased linearly with the number of HLA mismatches, particularly with four or more mismatches (2.3- to 2.9-fold increase).
• HLA-B and -DR mismatches showed the most significant association with acute rejection.
• HLA matching did not influence graft or patient survival but reduced the risk of opportunistic infections and associated hospital costs.

Conclusions:

• HLA matching is significant for reducing acute rejection in pancreas transplants, especially for solitary recipients.
• HLA matching is not a reliable predictor of pancreas graft survival.
• Implementing HLA matching can lead to substantial cost savings by reducing acute rejection and subsequent hospitalizations.